Genetic

GSS.AX

Tags: AU Healthcare Medical - Diagnostics & Research

Genetic Signatures Limited Price (GSS.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

165,264,402

(12.5692)%

Market Cap of Genetic (GSS.AX)

Market cap:

As of , GSS.AX has a market cap of . This makes GSS.AX the 537th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respirator... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.475-0.85
Market Cap 126.06M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Ms. Allison Rossiter
IPO Date: March, 30, 2015
Country: AU
Currency: AUD
Headquaters: Newtown, NSW
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: